Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats.

Amara VR, Surapaneni SK, Tikoo K.

PLoS One. 2017 Jul 20;12(7):e0180490. doi: 10.1371/journal.pone.0180490. eCollection 2017.

2.

Single nucleotide polymorphisms in microRNA genes are associated with cervical cancer susceptibility in a population from Xinjiang Uygur.

Yang J, Zhang Z, Guo W, Ma Y, Emin RM, Abudubari K, Hayrat G, Wali H, Qi X, Liu C, Ma M, Nurbek P.

Oncotarget. 2016 Nov 1;7(44):71447-71454. doi: 10.18632/oncotarget.12212.

3.

MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.

Zhang X, Ji W, Huang R, Li L, Wang X, Li L, Fu X, Sun Z, Li Z, Chen Q, Zhang M.

Oncotarget. 2016 Aug 16;7(33):53808-53819. doi: 10.18632/oncotarget.10780.

4.

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.

Su Y, Sun B, Lin X, Zhao X, Ji W, He M, Qian H, Song X, Yang J, Wang J, Chen J.

Oncotarget. 2016 Aug 2;7(31):49143-49155. doi: 10.18632/oncotarget.9237.

5.

MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.

Fernandez-Mercado M, Manterola L, Lawrie CH.

Curr Genomics. 2015 Oct;16(5):349-58. doi: 10.2174/1389202916666150707160147.

6.

MicroRNA Expression during Bovine Oocyte Maturation and Fertilization.

Gilchrist GC, Tscherner A, Nalpathamkalam T, Merico D, LaMarre J.

Int J Mol Sci. 2016 Mar 18;17(3):396. doi: 10.3390/ijms17030396.

7.

Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells.

Peralta-Zaragoza O, Deas J, Meneses-Acosta A, De la O-Gómez F, Fernández-Tilapa G, Gómez-Cerón C, Benítez-Boijseauneau O, Burguete-García A, Torres-Poveda K, Bermúdez-Morales VH, Madrid-Marina V, Rodríguez-Dorantes M, Hidalgo-Miranda A, Pérez-Plasencia C.

BMC Cancer. 2016 Mar 14;16:215. doi: 10.1186/s12885-016-2231-3.

8.

Transcriptional and post-transcriptional regulation of NK cell development and function.

Leong JW, Wagner JA, Ireland AR, Fehniger TA.

Clin Immunol. 2017 Apr;177:60-69. doi: 10.1016/j.clim.2016.03.003. Epub 2016 Mar 3. Review.

PMID:
26948928
9.

Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.

de la Parra C, Castillo-Pichardo L, Cruz-Collazo A, Cubano L, Redis R, Calin GA, Dharmawardhane S.

Nutr Cancer. 2016;68(1):154-64. doi: 10.1080/01635581.2016.1115104. Epub 2016 Jan 15.

10.

Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation.

Tokudome T, Sasaki A, Tsuji M, Udaka Y, Oyamada H, Tsuchiya H, Oguchi K.

Oncol Lett. 2015 Oct;10(4):2269-2272. Epub 2015 Aug 11.

11.

Role of Exosomal Noncoding RNAs in Lung Carcinogenesis.

Sun T, Kalionis B, Lv G, Xia S, Gao W.

Biomed Res Int. 2015;2015:125807. doi: 10.1155/2015/125807. Epub 2015 Oct 25. Review.

12.

Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway.

Zhuang Z, Xiao-qin, Hu H, Tian SY, Lu ZJ, Zhang TZ, Bai YL.

Mol Vis. 2015 Oct 13;21:1173-84. eCollection 2015.

13.

MicroRNA-155 and Its Role in Malignant Hematopoiesis.

Ranganath P.

Biomark Insights. 2015 Oct 22;10:95-102. doi: 10.4137/BMI.S27676. eCollection 2015. Review.

14.

Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Libânio D, Dinis-Ribeiro M, Pimentel-Nunes P.

World J Clin Oncol. 2015 Oct 10;6(5):111-32. doi: 10.5306/wjco.v6.i5.111. Review.

15.

In Vivo Inhibition of miR-155 Promotes Recovery after Experimental Mouse Stroke.

Caballero-Garrido E, Pena-Philippides JC, Lordkipanidze T, Bragin D, Yang Y, Erhardt EB, Roitbak T.

J Neurosci. 2015 Sep 9;35(36):12446-64. doi: 10.1523/JNEUROSCI.1641-15.2015.

16.

Phosphatase and Tensin Homologue: Novel Regulation by Developmental Signaling.

Jerde TJ.

J Signal Transduct. 2015;2015:282567. doi: 10.1155/2015/282567. Epub 2015 Aug 3. Review.

17.

Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.

Jiang YX, Du ZM, Jiao L, Shao Q, Fu S, Shao JY, Zhu XF, Ernberg I, Li YH.

Int J Clin Exp Med. 2015 Jun 15;8(6):8472-84. eCollection 2015.

18.

The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.

Liang L, Zhang Z, Wang Y, Nong L, Zheng Y, Qu L, Zhang B, Li T.

Biomed Res Int. 2015;2015:435423. doi: 10.1155/2015/435423. Epub 2015 Jun 29.

19.

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.

Khalife J, Radomska HS, Santhanam R, Huang X, Neviani P, Saultz J, Wang H, Wu YZ, Alachkar H, Anghelina M, Dorrance A, Curfman J, Bloomfield CD, Medeiros BC, Perrotti D, Lee LJ, Lee RJ, Caligiuri MA, Pichiorri F, Croce CM, Garzon R, Guzman ML, Mendler JH, Marcucci G.

Leukemia. 2015 Oct;29(10):1981-92. doi: 10.1038/leu.2015.106. Epub 2015 May 14.

20.

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia.

Gaudette BT, Dwivedi B, Chitta KS, Poulain S, Powell D, Vertino P, Leleu X, Lonial S, Chanan-Khan AA, Kowalski J, Boise LH.

Oncogene. 2016 Jan 28;35(4):479-90. doi: 10.1038/onc.2015.103. Epub 2015 Apr 20.

Supplemental Content

Support Center